SCOTUS Upholds Mifepristone Access
In a unanimous 9-0 decision on June 13, 2024, the U.S. Supreme Court rejected a challenge to the abortion pill mifepristone, thereby preserving broad nationwide access to the drug used in over 60% of U.S. abortions. The Court ruled that anti-abortion doctors and groups lacked legal standing to sue, emphasizing that plaintiffs failed to demonstrate concrete harm and averting a potential nationwide ban.